Cargando…

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis

BACKGROUND & AIMS: Prophylaxis with nucleos(t)ide analogues (NUCs) and hepatitis B immunoglobulin (HBIG) has decreased the rate of HBV recurrence after orthotopic liver transplantation (OLT), but the duration of this prophylaxis remains debated. Our aim was to investigate the recurrence of both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villeret, François, Lebossé, Fanny, Radenne, Sylvie, Samuel, Didier, Roche, Bruno, Mabrut, Jean-Yves, Leroy, Vincent, Pageaux, Georges-Philippe, Anty, Rodolphe, Thevenon, Sylvie, Ahmed, Sinafa Si, Hamilton, Aaron, Heil, Marintha, Scholtès, Caroline, Levrero, Massimo, Testoni, Barbara, Zoulim, Fabien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131114/ https://www.ncbi.nlm.nih.gov/pubmed/37122357 http://dx.doi.org/10.1016/j.jhepr.2023.100728

Ejemplares similares

Evaluation of the HBV liver reservoir with fine needle aspirates
por: Testoni, Barbara, et al.
Publicado: (2023)

Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis
por: Chouik, Yasmina, et al.
Publicado: (2023)

Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio
por: Riff, Arnaud, et al.
Publicado: (2023)

Liver Transplantation for Colorectal Liver Metastases: Current Management and Future Perspectives
por: Puia-Negulescu, Serban, et al.
Publicado: (2021)

Gene Editing Technologies to Target HBV cccDNA
por: Martinez, Maria Guadalupe, et al.
Publicado: (2022)

The Potential Implication of the Autonomic Nervous System in Hepatocellular Carcinoma
por: Parent, Romain, et al.
Publicado: (2019)

Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients
por: Lebossé, Fanny, et al.
Publicado: (2020)

Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
por: Allweiss, Lena, et al.
Publicado: (2023)

Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus
por: Chemin, Isabelle, et al.
Publicado: (2021)

Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017
por: Charre, Caroline, et al.
Publicado: (2017)

Genome-wide identification of direct HBx genomic targets
por: Guerrieri, Francesca, et al.
Publicado: (2017)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
por: Roche, Bruno, et al.
Publicado: (2022)

Effects of costimulation on intrahepatic immunopathogenesis in patients with chronic HBV infection
por: Zhong, Bei, et al.
Publicado: (2013)

Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication
por: Barral, Karine, et al.
Publicado: (2011)

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model
por: Brusset, Bleuenn, et al.
Publicado: (2021)

Preoperative prediction model for microvascular invasion in HBV-related intrahepatic cholangiocarcinoma
por: Yu, Liang, et al.
Publicado: (2023)

The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond
por: Alfano, Vincenzo, et al.
Publicado: (2021)

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
por: Meunier, Lucy, et al.
Publicado: (2022)

Economic Study of 2-Stage Exchange in Patients With Knee or Hip Prosthetic Joint Infection Managed in a Referral Center in France: Time to Use Innovative(s) Intervention(s) at the Time of Reimplantation to Reduce the Risk of Superinfection
por: Serrier, Hassan, et al.
Publicado: (2021)

Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B
por: Svicher, Valentina, et al.
Publicado: (2021)

Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis
por: Adhoute, Xavier, et al.
Publicado: (2023)

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
por: Lin, Su-Ru, et al.
Publicado: (2014)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
por: Aggarwal, Abhishek, et al.
Publicado: (2022)

Landscape of oncoviral genotype and co-infection via human papilloma and hepatitis B viral tumor in situ profiling
por: Bubie, Adrian, et al.
Publicado: (2021)

Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?
por: Adhoute, Xavier, et al.
Publicado: (2020)

Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
por: Wang, Xiaomei, et al.
Publicado: (2021)

A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
por: Huang, Xiaoli, et al.
Publicado: (2023)

Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma
por: Pollicino, Teresa, et al.
Publicado: (2019)

Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection
por: Hou, Jun, et al.
Publicado: (2017)

Comparison of Serum HBsAg Quantitation by Four Immunoassays, and Relationships of HBsAg Level with HBV Replication and HBV Genotypes
por: Tuaillon, Edouard, et al.
Publicado: (2012)

Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol Consumption
por: Coker, Melynda S., et al.
Publicado: (2020)

Variability in the Precore and Core Promoter Regions of HBV Strains in Morocco: Characterization and Impact on Liver Disease Progression
por: Kitab, Bouchra, et al.
Publicado: (2012)

MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study)
por: Gelu-Simeon, Moana, et al.
Publicado: (2015)

Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma
por: Shen, Yifei, et al.
Publicado: (2023)

Correction: End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial—HOPExt
por: Pradat, Pierre, et al.
Publicado: (2023)

End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial—HOPExt
por: Pradat, Pierre, et al.
Publicado: (2023)

New anti-HCV agents in the pipeline
por: Zoulim, Fabien
Publicado: (2014)

HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature
por: Wang, Caixia, et al.
Publicado: (2016)

Baseline value of intrahepatic HBV DNA over cccDNA predicts patient’s response to interferon therapy
por: Mu, Di, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d2d909uo8ksol1u1sb2jm53s3u